Biofilms and chronic infection

01Key questions

02What Are Biofilms?

Biofilms are highly organized communities of bacteria (and other microorganisms) that adhere to surfaces and encase themselves in a self-produced, protective shield called an exopolysaccharide (EPS) matrix. They function as microbial "fortresses."

"An easy way to think about it: the bacteria are grouped together in a castle, and this matrix acts like a moat around a castle, protecting the bacteria from its enemies like antibiotics and our immune system." — Lyme Warrior

Key Characteristics

• Protection: Shields the bacterial colony from immune system detection and harsh environments
• Communication: Bacteria share nutrients and information via quorum sensing, strengthening the colony
• Ubiquity: Found everywhere — teeth (plaque), sinks, medical devices, and inside the human body
• Resilience: Can be 10-1000x more resistant to antibiotics than free-floating (planktonic) bacteria

03Structure of a Biofilm

┌──────────────────────────────────────────┐
│         EPS MATRIX (the "moat")          │
│  ┌──────┐  ┌──────┐  ┌──────┐          │
│  │Bact. │  │Bact. │  │Bact. │ ← Dormant │
│  │  A   │  │  B   │  │  C   │   persister│
│  └──────┘  └──────┘  └──────┘   cells    │
│     ↕ Quorum sensing channels ↕          │
│  ┌──────┐  ┌──────┐  ┌──────┐          │
│  │Bact. │  │Bact. │  │Fungi │ ← Active  │
│  │  D   │  │  E   │  │Cand. │   microbes│
│  └──────┘  └──────┘  └──────┘          │
│         ↓↓↓ Sequestered minerals ↓↓↓    │
│      (Ca²⁺, Mg²⁺, Fe²⁺, heavy metals)  │
└──────────────────────────────────────────┘

Components of the Matrix

1. Exopolysaccharides (EPS): The primary structural scaffold
2. Fibrin/fibrinogen: Recruited by bacteria to give structural integrity
3. Sequestered minerals: Calcium, magnesium, iron (and potentially heavy metals)
4. DNA: Extracellular DNA from lysed cells contributes to matrix stability
5. Proteins: Various structural and functional proteins

04How Biofilms Protect Pathogens

1. Antibiotic Impenetrability

The matrix acts as a physical barrier, causing "antibiotic tolerance" where bacteria inside survive and can repopulate once treatment stops. Antibiotics that do penetrate may actually foster biofilm formation.

2. Immune System Evasion

The matrix cloaks surface antigens and dampens the host's inflammatory response, making bacteria virtually unrecognizable to immune cells.

3. Persister Cells

Biofilms harbor dormant "persister cells" — bacteria in a hibernation state with extremely low metabolic activity. These survive harsh conditions (including antibiotics that target active metabolism) and can resuscitate to re-initiate infection when conditions improve.

4. Chronic Inflammation

Biofilm structures and bacterial components continuously trigger pro-inflammatory cytokines, leading to ongoing tissue damage, fatigue, and pain.

5. Quorum Sensing

Bacteria communicate through chemical signals to coordinate colony behavior, including biofilm formation, virulence, and dispersal. Disrupting quorum sensing is a key therapeutic strategy.

05Biofilm-Forming Organisms

Swipe table →

06Prevalence and Clinical Significance

• An estimated 80% of all GI infections involve biofilm-producing microbes
• 65% of all bacterial infections in humans are biofilm-associated (NIH estimate)
• Biofilms are a primary reason infections become chronic and treatment-resistant
• Standard stool cultures often miss biofilm-hidden organisms

07Signs of Biofilm Infection

• Minimal/no pathogenic infections on stool tests despite chronic symptoms
• New infections appearing on retest after antimicrobial treatment (biofilm disrupted enough to release them)
• Previous treatments without biofilm disruptors failed
• Symptoms that improve temporarily with antimicrobials but always return
• Chronic low-grade inflammation, fatigue, brain fog

08Recent Evidence (2024–2026)

Quorum-sensing / tolerance mechanisms

• 2025 review (Frontiers in Microbiology, Zhang et al., DOI 10.3389/fmicb.2025.1619626) — P. aeruginosa integrates quorum sensing (las, rhl, pqs), T3SS effectors (ExoS ADP-ribosyl transferase blocks lysosome-autophagy in host cells), and biofilm formation as a unified pathogenic strategy. ExoS inhibits endocytic vesicle acidification, helping bacteria evade intracellular killing and create a permissive niche for chronic infection. URL: https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2025.1619626/full
• 2026 review (Frontiers in Cellular and Infection Microbiology, DOI 10.3389/fcimb.2026.1826282) — "Biofilm-associated antibiotic tolerance in the era of multidrug resistance" consolidates the modern view: tolerance ≠ classical resistance. Persister cells and matrix-protected populations survive lethal concentrations of bactericidal drugs, then repopulate once therapy ends. Quorum-sensing inhibitors (QSIs) and CRISPR-Cas9-based biofilm disruption are emerging as adjuncts. URL: https://www.frontiersin.org/journals/cellular-and-infection-microbiology/articles/10.3389/fcimb.2026.1826282/full
• 2025 npj Biofilms & Microbiomes (Sahu & Ruhal, DOI 10.1038/s41522-025-00738-2) — P. aeruginosa biofilm actively rewires host immunity: alveolar macrophage function, neutrophil extracellular matrix interactions, and endotracheal-tube biofilm epidemiology (PMID 38522457). URL: https://www.nature.com/articles/s41522-025-00738-2
• 2025 npj Biofilms & Microbiomes (Brandquist et al., DOI 10.1038/s41522-025-00782-y) — S. aureus biofilm-associated implant infections drive MDSC (myeloid-derived suppressor cell) expansion and granulocytic MDSC heterogeneity (J Leukoc Biol 2024 PMID ref), dampening adaptive immunity. Single-dose nanoparticle monocyte/Mφ-polarizing therapy synergized with systemic antibiotics and reduced bacterial burden below the limit of detection in a mature biofilm model. URL: https://www.nature.com/articles/s41522-025-00782-y

Ciguatoxin / CIRS transcriptomics (Ryan et al. 2015; re-cited 2025)

• PMID 25889530 (Ryan JC, Wu Q, Shoemaker RC. BMC Med Genomics 2015;8:15, DOI 10.1186/s12920-015-0089-x) — Whole-blood transcriptomic profiling in 11 ciguatera-induced CIRS patients vs 11 controls identified dysregulation of innate immunity (GZMK, TOLLIP, SIGIRR, VIPR2) and adaptive immunity (HLA-DQB1, DQB2, IL18R1, IL5RA) genes. Disruption in the HLA–T-cell receptor axis is consistent with the HLA haplotype susceptibility model used in Shoemaker's CIRS/mold protocol. Re-cited in 2025 ME/CFS work (J Transl Med 2025 23:149) and 2025 CIRS/ME-CFS transcriptomic expansion reviews. PDF in Sources/Papers/doi_10.1186_s12920-015-0089-x.pdf.

Mixed fungal–bacterial biofilms (inter-kingdom)

• 2025 review (PMC13354734, Microorganisms) — Mixed respiratory fungal–bacterial infections feature interkingdom signaling (quorum-sensing molecules like farnesol, homoserine lactones cross-talk). Aspergillus and Candida biofilms synergize with bacterial pathogens (P. aeruginosa, S. aureus) and substantially elevate antimicrobial tolerance. URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC13354734/
• 2024 J Hazard Mater (Chang et al., DOI 10.1016/j.jhazmat.2024.134617) — Multi-species Aspergillus (A. niger, A. flavus) biofilms form readily in water systems and on surfaces; they are the dominant form in environmental reservoirs relevant to water-damaged building exposure.

Persister cell and tolerance biology — 2024–2025 update

• Sub-inhibitory antibiotic paradox: Multiple 2024–2025 studies confirm that antibiotics at sub-MIC levels can induce biofilm formation rather than disperse it (e.g., ciprofloxacin, tobramycin). This is a key reason empirical "more antibiotics" strategies can backfire in chronic infection. Referenced in the Hindieh et al. 2025 Microorganisms multimodal-eradication review (DOI 10.3390/microorganisms13122796).
• Efflux-pump contribution: Matrix-embedded cells over-express efflux pumps (MexAB-OprM, NorA, AdeABC), actively expelling antibiotics that do penetrate. This is active tolerance, not just physical barrier.

10Connections

11Sources

1. DOI 10.3389/fmicb.2025.1619626DOI 10.3389/fmicb.2025.1619626
2. DOI 10.3389/fcimb.2026.1826282DOI 10.3389/fcimb.2026.1826282
3. DOI 10.1038/s41522-025-00738-2DOI 10.1038/s41522-025-00738-2
4. PubMed 38522457PubMed 38522457
5. Brandquist et al. 2025 (npj Biofilms Microbiomes 11:__, DOI 10.1038/s41522-025-00782-y ) — S. aureus biofilm infection expands myeloid-derived suppressor cells (MDSCs) and polarizes monocytes/macrophages toward a permissive phenotype. The biofilm also reduces neutrophil recruitment (delayed NETosis), which is a key evasion mechanism. A single dose of monocyte/Mφ-repolarizing nanoparticles synergized with systemic antibiotics and dropped bacterial burden below detection in a mature biofilm model. URL: https://www.nature.com/articles/s41522-025-00782-yDOI 10.1038/s41522-025-00782-y
6. PubMed 25889530PubMed 25889530
7. DOI 10.1186/s12920-015-0089-xDOI 10.1186/s12920-015-0089-x
8. PMC13354734PMC13354734
9. DOI 10.1016/j.jhazmat.2024.134617DOI 10.1016/j.jhazmat.2024.134617
10. DOI 10.3390/microorganisms13122796DOI 10.3390/microorganisms13122796
11. Feng et al. 2020 (Front Med Technol; PMC7050641 ; PMID 32033522 ) — Johns Hopkins team (Feng, Leone, Sapi, Zhang et al.) head-to-head tested 14 botanicals against B. burgdorferi in growing and stationary (persister) phases:PMC7050641 · PubMed 32033522
12. Stevia whole-leaf extract — active against biofilm mass and spirochetes (consistent with Theophilus 2015 PMID 26716015 ) but did not eradicate stationary-phase persisters in subculture.PubMed 26716015
13. Peng et al. 2017 (PLOS ONE 12(8):e0183271, PMID 28837601 ) — foundational paper showing S. aureus biofilm treatment expands MDSCs and enhances their immunosuppressive activity — a primary mechanism by which biofilms evade adaptive immunity. URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0183271PubMed 28837601

12Entry history

Heretic informs and never prescribes. Where amounts appear, they describe what published studies used. Talk to a qualified clinician before acting on anything here.